A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
一项随机、非对照的 2 期研究，评估新辅助免疫检查点阻断治疗腹膜后去分化脂肪肉瘤和肢体/躯干未分化多形性肉瘤的疗效。
期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-024-00726-z
Roland Christina L, Nassif Haddad Elise F, Keung Emily Z, Wang Wei-Lien, Lazar Alexander J, Lin Heather, Chelvanambi Manoj, Parra Edwin R, Wani Khalida, Guadagnolo B Ashleigh, Bishop Andrew J, Burton Elizabeth M, Hunt Kelly K, Torres Keila E, Feig Barry W, Scally Christopher P, Lewis Valerae O, Bird Justin E, Ratan Ravin, Araujo Dejka, Zarzour M Alexandra, Patel Shreyaskumar, Benjamin Robert, Conley Anthony P, Livingston J Andrew, Ravi Vinod, Tawbi Hussein A, Lin Patrick P, Moon Bryan S, Satcher Robert L, Mujtaba Bilal, Witt Russell G, Traweek Raymond S, Cope Brandon, Lazcano Rossana, Wu Chia-Chin, Zhou Xiao, Mohammad Mohammad M, Chu Randy A, Zhang Jianhua, Damania Ashish, Sahasrabhojane Pranoti, Tate Taylor, Callahan Kate, Nguyen Sa, Ingram Davis, Morey Rohini, Crosby Shadarra, Mathew Grace, Duncan Sheila, Lima Cibelle F, Blay Jean-Yves, Fridman Wolf Herman, Shaw Kenna, Wistuba Ignacio, Futreal Andrew, Ajami Nadim, Wargo Jennifer A, Somaiah Neeta
